The expression of APOA1 in control pancreas and severe down-regulation in pancreas with T2D is very novel and important finding, which open new avenues on lipid metabolism, HDL, cardiovascular events, diabetes and its complications such as neuropathies, and will help to design new future studies. This evidence concerns the gene APOA1 and neuropathy.